Clinical significance of glucocorticoid receptor expression in premature infants with respiratory distress syndrome

2016 ◽  
Vol 30 (4) ◽  
pp. 430-433 ◽  
Author(s):  
Fevzi Ataseven ◽  
Osman Salis ◽  
Canan Aygun ◽  
Abdulkerim Bedir ◽  
Sukru Kucukoduk
1981 ◽  
Vol 15 ◽  
pp. 667-667
Author(s):  
Alan H Klein ◽  
Barbara Foley ◽  
Thomas P Foley ◽  
Hugh H Macdonald ◽  
Delbert A Fisher

PEDIATRICS ◽  
1973 ◽  
Vol 52 (6) ◽  
pp. 782-787 ◽  
Author(s):  
Melvin Baden ◽  
Charles R. Bauer ◽  
Eleanor Colle ◽  
George Klein ◽  
Apostolos Papageorgiou ◽  
...  

Plasma total corticosteroid concentrations were measured in 44 premature infants with the respiratory distress syndrome (RDS). Further assay of serum concentrations of cortisol, cortisone, corticosterone, corticosterone sulfate, and 11-deoxycorticosterone sufate was carried out in 24 of these infants and in 10 healthy, nonstressed premature controls. Infants with RDS had higher concentrations of cortisol (22.1±4.3µg/100 ml) and corticosterone sulfate (7.7 ± 0.8 µg/100 ml) than control infants (6.6 ± 0.8 µg/100 ml, 1.2 ± 0.3 µg/100 ml, and 4.2 ± 0.4 µg/100 ml, respectively). A significant correlation was found with the five-minute Apgar score (negative correlation, p = 0.005) and a possible correlation with the A-aDO2 gradient. Among premature infants with RDS, those of 32 weeks' gestation or less had higher concentrations of cortisol (28.3 ± 23.6 µg/100 ml) and corticosterone (3.9 ± 2.7 µg/100 ml) than those of more than 32 weeks (11.5 ± 5.4 µg/100 ml and 1.7 ± 0.7 µg/100 ml, respectively), suggesting either elevated response to stress or a diminished ability to metabolize these compounds.


Neonatology ◽  
1971 ◽  
Vol 17 (1-2) ◽  
pp. 98-111 ◽  
Author(s):  
Marguerite Markarian ◽  
L.O. Lubchenco ◽  
Eliana Rosenblüt ◽  
F. Fernandez ◽  
D. Lang ◽  
...  

2020 ◽  
Vol 20 (1) ◽  
pp. 437-443
Author(s):  
Pelin Dogan ◽  
Hilal Ozkan ◽  
Nilgun Koksal ◽  
Onur Bagci ◽  
Ipek Guney Varal

Background: The positive effects of steroids on lung development are well known, and 1,25-dihydroxy vitamin D3 has been shown to exert positive effects on fetal lung development. Objective: We aimed to investigate the relationship between 25-hydroxyvitamin D [25(OH)D] levels and respiratory distress syn- drome (RDS) in premature infants. Methods: Infants aged ≤32 gestational weeks who were admitted to the neonatal intensive care unit (NICU) during 1 year were enrolled in this prospective study. 25(OH)D levels were obtained at the time of admission to NICU. Patients were divided into three groups according to their 25(OH)D levels: severe (group 1), moderate (group 2), and mild (group 3) 25(OH)D deficiencies. Results: The study comprised 72 patients; of them, RDS was observed in 49 and not observed in 23 patients. The mean 25(OH)D levels were significantly lower in RDS patients (p=0.04). Multivariate analysis showed that patients with higher 25(OH)D levels can be preventive for the development of RDS (odds ratio 0.89; 95% confidence interval 0.8–0.99; p=0.04). Conclusion: Our study revealed that 25(OH)D deficiency is an independent risk factor for RDS in premature infants. However, further studies are necessary to explore the association between 25(OH)D deficiency and RDS. Keywords: 25-hydroxyvitamin D; prematurity; respiratory distress syndrome. 


Sign in / Sign up

Export Citation Format

Share Document